Form 4 for SNA Snap-on
Accepted 2025-02-11 00:00:00 ET · period of report 2025-02-10 · accession 0001127602-25-004229 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-11 | 2025-02-10 | SNA | Arregui Jesus | SVP, Pres - Commercial | S - Sale+OE | $337.82 | -6,451 | 257.27 | -96% | -$2.18M |
| D | 2025-02-11 | 2025-02-10 | SNA | Arregui Jesus | SVP, Pres - Commercial | F - Tax | $340.61 | -610 | 1,015 | -38% | -$207.8K |
| DM | 2025-02-11 | 2025-02-10 | SNA | Arregui Jesus | SVP, Pres - Commercial | M - OptEx | $155.92 | +13.4K | 12.3K | New | +$2.08M |
| D | 2025-02-11 | 2025-02-10 | SNA | Arregui Jesus | SVP, Pres - Commercial | D - Sale to Iss | $337.19 | -5,549 | 6,708 | -45% | -$1.87M |
| DM | 2025-02-11 | 2025-02-10 | SNA | Arregui Jesus | SVP, Pres - Commercial | M - OptEx | — | -13.4K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-10 | S | D | 3,302 | $338.26 | 3,406.27 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $337.90 to $338.83. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
| 2 | Common | Common Stock | 2025-02-10 | F | D | 610 | $340.61 | 1,015.27 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-10 | M | A | 1,368 | — | 1,625.27 | D | — | — | (F4) The restricted stock units reported above vested on the date indicated based on continued employment of the reporting person throughout the three-year restricted period. |
| 4 | Common | Common Stock | 2025-02-10 | S | D | 3,149 | $337.35 | 257.27 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $336.83 to $337.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
| 5 | Common | Common Stock | 2025-02-10 | D | D | 5,549 | $337.19 | 6,708.27 | D | — | — | |
| 6 | Common | Common Stock | 2025-02-10 | M | A | 12,000 | $155.92 | 12,257.27 | D | — | — | (F1) Includes 5.0021 shares acquired under a dividend reinvestment plan. |
| 7 | Derivative | Restricted Stock Units | 2025-02-10 | M | D | 1,368 | — | 0 | D | — · 2025-02-10 to 2025-02-10 | 1,368 Common Stock | (F4) The restricted stock units reported above vested on the date indicated based on continued employment of the reporting person throughout the three-year restricted period. (F8) 1 for 1. |
| 8 | Derivative | Stock Appreciation Rights | 2025-02-10 | M | D | 12,000 | — | 0 | D | $155.92 · — to 2029-02-14 | 12,000 Common Stock | (F7) Exercise of Rule 16b-3 stock appreciation rights. (F6) Stock appreciation rights grant fully vested. |